Work

Pathogenic TP53 mutations Are Associated with a Poor Prognosis in De Novo AML

Year: 2022

Type: article

Source: Blood

DOI: 10.1182/blood-2022-162832

Authors: Adam J. Lamble, Rhonda E. Ries, Alice Dang, Todd A. Alonzo, Karen Chisholm, Pandurang Kolekar, Yanling Liu, Quang Tran, Todd M. Cooper, Richard Aplenc, Alan S. Gamis, Edward A. Kolb, Xiaotu Ma, Soheil Meshinchi

Institutions: Seattle Children's Hospital, Fred Hutch Cancer Center, Children's Oncology Group, University of Southern California, St. Jude Children's Research Hospital, Children's Hospital of Philadelphia, Children's Mercy Hospital, Alfred I. duPont Hospital for Children

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310108109

FWCI:

Cites:

Cited by:

Related to: 10